source
- BeOne secures FDA approval for lymphoma therapyBeOne received FDA approval for its lymphoma therapy, a notable achievement in a crowded therapeutic area. The agency’s review concluded that the treatment meets safety and efficacy standards, pla…
- Regenxbio reports successful Duchenne gene therapy trial, clearing path to FDA filingRegenxbio announced that its experimental gene therapy for Duchenne muscular dystrophy met its primary endpoints in a recent clinical trial, producing sufficient levels of a truncated muscle protei…